IfPA’s Patient Access Policy Blog

New Video Explores Health Plan Specialty Tiers

When you pick up your monthly prescription at the pharmacy counter, you may owe a co-pay of $10 or $20. Or you may pay much,

Read More

Living with Stigma

Living with a movement disorder means living with stigma.   Stares, whispers and pointing are just another part of the disease burden for the millions

Read More

New Data, Same Access Challenges for Heart Patients

The risk of death may be lower for certain patients taking cholesterol-lowering PCSK9 inhibitors, new research shows.  But how many patients will actually be able

Read More

IfPA Report Cards: 1 in 4 Heart Patients Can’t Access Innovative Rx

Health plans said “no” to one in every four Americans whose doctor prescribed a cholesterol-lowering PCSK9 inhibitor in 2017.  And that, according to the Institute

Read More

Working Group Airs Concerns about Access to Diabetes Care

There was a lot of head nodding at the inaugural meeting of the Alliance for Patient Access’ Diabetes Therapy Access Working Group.  Especially when the

Read More

Europeans Work to Turn Health Care Rights into Realities

by Brian Kennedy, Executive Director, Alliance for Patient Access Declaring equal rights is a noble gesture.  But history teaches us that it is just the first

Read More

Balancing Opioid Policy and Pain Management

Is Washington finally ready to address the nation’s opioid crisis in a meaningful way? Thursday marked the White House Opioid Summit, which welcomed 200 affected

Read More

Making Treatment Less Rare for Rare Disease Patients

Waiting is a fact of life for patients with rare diseases such as cystic fibrosis.   Many of these men and women, whose disease causes

Read More

Should Medicaid Patients be Required to Work?

Patients covered by Medicaid in Kentucky and Indiana could soon find themselves in a difficult position. According to new rules, recipients must complete 80 hours

Read More

New Video Explains Drug Track-and-Trace Process

It might be itching, chills, fatigue or sleeplessness. Side effects are common with prescription drugs. So how do regulators, patients and physicians keep tabs on

Read More
Back to Top